The FDA has released their list of planned guidance documents for 2023. This includes, but is not limited to, a transition plan for medical devices that were issued EUAs as well as technical guidance for software and cybersecurity functions. So as you begin your planning for next year, these topics may help focus your compliance efforts.

Reference the document A-list and B-list here.